Can Ketamine Therapy Be the Solution for Treatment Resistant Depression & Opioid Addiction?
Ketamine therapy is shaping up to be one of the…
Psychedelic Spotlight News
DMT is Effective at Treating Depression, New Study Finds
DMT is a powerful hallucinogen that can conjure visions of entities and alien worlds, but new research shows it can also treat depression.
Cybin Acquires Entheon’s DMT Trial, Numi’s Novamind Acq. Complete, Bad News for MindMed and More
This week in psychedelic business news: Cybin acquires a Phase…
Is the Mystical Experience Necessary for Psychedelic Therapy?
Recent research suggests that mystical experiences may be one of the best predictors of positive outcomes in psychedelic therapy.
Remembering Psychedelic Chemist Alexander Shulgin
Alexander Shulgin was the greatest psychoactive chemist of the 20th century. James Kent recollects his visit to Shulgin’s lab in the final days before his passing.
Psychedelic Business Spotlight – June 17
This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!
Music as Medicine – Music’s Role in Mental Health & Psychedelic Therapy | Payton Nyquvest
In this segment of Spotlight In Focus, Psychedelic Spotlight’s Matthew…
The Four Psychedelics ETFs Capturing Investor Attention
Despite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and size. This leads them to having different sized stakes companies, and their long-term success will vary.
Examining Ketamine Therapy with Myriam Barthes, Journey Clinical
In today’s episode, Myriam describes the impact of ketamine on the mind and the body, and specifically how ketamine therapy compares to other psychedelic-assisted therapies.
“Magic Mushroom Rabbi” Faces Jail Time as He Fights for Religious Freedom
Ben Gorelick, the “Magic Mushroom Rabbi”, faces prison time as he fights for the right to use magic mushrooms in religious ceremony.
End of content
End of content